UNITY Biotechnology Inc UBX:NASDAQ

Last Price$1.21NASDAQ Previous Close - Last Trade as of 4:00PM ET 1/21/22

Today's Change-0.03(2.42%)
Bid (Size)$1.25 (2)
Ask (Size)$1.27 (2)
Day Low / High$1.19 - 1.26
Volume959.0 K

View Biotechnology IndustryPeer Comparison as of 01/21/2022


UNITY Biotechnology Inc ( NASDAQ )

Price: $1.21
Change: -0.03 (2.42%)
Volume: 959.0 K
4:00PM ET 1/21/2022

Capricor Therapeutics Inc ( NASDAQ )

Price: $2.89
Change: -0.05 (1.70%)
Volume: 109.2 K
4:00PM ET 1/21/2022

DiaMedica Therapeutics Inc ( NASDAQ )

Price: $2.65
Change: -0.18 (6.36%)
Volume: 159.7 K
3:59PM ET 1/21/2022

vTv Therapeutics Inc ( NASDAQ )

Price: $0.77
Change: -0.09 (10.58%)
Volume: 447.4 K
3:59PM ET 1/21/2022

Evofem Biosciences Inc ( NASDAQ )

Price: $0.42
Change: -0.009 (2.16%)
Volume: 3.0 M
4:00PM ET 1/21/2022

Read more news Recent News

Roth Capital Upgrades Unity Biotechnology to Buy From Neutral, Keeps $4 Price Target
1:04PM ET 1/04/2022 MT Newswires

Unity Biotechnology (UBX) has an average rating of Outperform and price targets ranging from $4 to $12, according to analysts polled by Capital IQ. (MT...

Unity Biotechnology Signs Licensing Deal With Jocasta Neuroscience for Alpha-Klotho Program Development
11:06AM ET 12/20/2021 MT Newswires

Unity Biotechnology (UBX) said Monday it has entered into an exclusive licensing deal with Jocasta Neuroscience for the development and commercialization...

Wedbush Starts Unity Biotechnology at Outperform With $4 Price Target
6:36AM ET 12/15/2021 MT Newswires

Unity Biotechnology (UBX) has an average rating of outperform and price targets ranging from $4 to $12, according to analysts polled by Capital IQ. (MT...

Top Premarket Decliners
8:19AM ET 12/08/2021 MT Newswires

Ensysce Biosciences (ENSC) shares slumped 26%, in premarket trading Wednesday, paring Tuesday's rally. Stitch Fix (SFIX) shares declined 25% after the...

View all Commentary and Analysis

A Look At Unity's UBX1325 Phase 1 Results
4:11PM ET 7/26/2021 Seeking Alpha

Our First Take On Unity Biotechnology
10:17AM ET 4/08/2021 Seeking Alpha

Unity Biotechnology (UBX) Investor Presentation - Slideshow
5:06PM ET 3/15/2021 Seeking Alpha

Company Profile

Business DescriptionUnity Biotechnology, Inc. operates as a biotechnology company. The firm is developing a portfolio of programs like biological mechanisms implicated in diseases of aging, and also senolytic programs in ophthalmologic and neurologic disorders. The company was founded by Nathaniel Eames David, Jan van Deursen, Judith Campisi, and Daohong Zhou on March 30, 2009 and is headquartered in Brisbane, CA. View company web site for more details
Address285 East Grand Avenue
South San Francisco, California 94080
Number of Employees106
Recent SEC Filing12/20/20218-K
Chief Executive Officer & DirectorAnirvan Ghosh
Vice President-OperationsNathan Guz
Chief Financial OfficerLynne Sullivan
Chief Medical OfficerJamie Dananberg

Company Highlights

Price Open$1.23
Previous Close$1.24
52 Week Range$1.19 - 9.78
Market Capitalization$69.8 M
Shares Outstanding57.7 M
SectorHealth Technology
Next Earnings Announcement03/22/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$1.27
Beta vs. S&P 500N/A
Net Profit MarginN/A
Return on Equity-97.06%

Analyst Ratings as of 01/04/2022

Consensus RecommendationConsensus Icon
Powered by Factset